| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00292-010-1278-1 |
| P698 | PubMed publication ID | 20443098 |
| P2093 | author name string | R Büttner | |
| M Dietel | |||
| H Höfler | |||
| J Rüschoff | |||
| W Schlake | |||
| H H Kreipe | |||
| H U Schildhaus | |||
| G Baretton | |||
| O Stoss | |||
| I Nagelmeier | |||
| P2860 | cites work | Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer | Q34713799 |
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q36678853 | ||
| Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients | Q37135262 | ||
| Assessment of a HER2 scoring system for gastric cancer: results from a validation study | Q37142266 | ||
| HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing | Q42431264 | ||
| HER-2 amplification is highly homogenous in gastric cancer. | Q51779078 | ||
| Close association between HER-2 amplification and overexpression in human tumors of non-breast origin | Q79954721 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 208-217 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Pathologe | Q15749166 |
| P1476 | title | [Her2 testing in gastric cancer. What is different in comparison to breast cancer?]. | |
| P478 | volume | 31 |
| Q36897947 | Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population |
| Q38083585 | Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population |
| Q38314355 | HER2 assessment by silver in situ hybridization: where are we now? |
| Q42431264 | HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing |
| Q30837184 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer |
| Q37308782 | HER2 status in gastric and gastroesophageal junction cancer assessed by local and central laboratories: Chinese results of the HER-EAGLE study |
| Q28256814 | HER2 testing in gastric cancer: a practical approach |
| Q39174711 | HER2 testing in gastric cancer: results of a German expert meeting |
| Q60915393 | HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma |
| Q35211652 | Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study. |
| Q34216289 | Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization |
| Q92890756 | Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma |
| Q36001921 | Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer |
| Q92450415 | Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma |
| Q37959106 | Molecular pathology of gastric carcinoma |
| Q44468300 | Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection |
| Q37687784 | Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm |
| Q34730478 | Serum HER 2 extracellular domain level is correlated with tissue HER 2 status in metastatic gastric or gastro-oesophageal junction adenocarcinoma |
| Q54569855 | Trastuzumab in HER2-positive metastatic gastric cancer: profile report. |
| Q37846228 | Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancer |
| Q37809845 | Trastuzumab: in HER2-positive metastatic gastric cancer |
| Q53073585 | [HER2 testing in gastric cancer : Results of a meeting of German experts]. |
Search more.